Lv1
48 积分 2020-12-22 加入
Unmet Needs of Patients with Parkinson's Disease: Interview Survey of Patients and Caregivers
1天前
已完结
Unmet needs of people with Parkinson’s disease: A cross‐sectional study
1天前
已完结
Unmet needs in the pharmacological management of motor symptoms in Parkinson's disease
1天前
已完结
Unmet needs in Parkinson's disease: New horizons in a changing landscape
1天前
已完结
What is the impact of catechol-O-methyltransferase (COMT) on Parkinson’s disease treatment?
1天前
已完结
Gender Differences in Efficacy and Tolerability of Opicapone in Add on of Levodopa. A Single-Center Retrospective Cohort Study
1天前
已完结
Safety of COMT-inhibitors in parkinson’s disease: a phase-IV comparative study on adverse events of Tolcapone, Entacapone and Opicapone
1天前
已完结
Impact of concomitant use of opicapone during levodopa–carbidopa intestinal gel treatment
1天前
求助中
Real-world safety profile of opicapone: a comprehensive pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
1天前
已完结
Long-term follow up of opicapone as add-on to levodopa in Parkinson's patients without motor fluctuations
1天前
已完结
皖公网安备34019202002308
